Related Experiment Video
Updated: Jul 5, 2026
06:18
An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Easing vasomotor symptoms: Besides HRT, what works?
1Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Summary
Hormone replacement therapy (HRT) effectively treats vasomotor symptoms, but alternative options like soy isoflavones, black cohosh, and lifestyle changes exist for those concerned about risks. Personalized treatment plans are essential for managing menopausal symptoms.
Area of Science:
- Menopause and Women's Health
- Endocrinology
- Pharmacology
Background:
- Hormone replacement therapy (HRT) is highly effective for managing vasomotor symptoms associated with menopause.
- However, some patients perceive risks associated with conventional HRT, necessitating exploration of alternative treatments.
- Understanding the efficacy and safety profiles of various therapeutic options is crucial for patient-centered care.
Purpose of the Study:
- To review the effectiveness and risks of different therapies for vasomotor symptoms.
- To compare conventional HRT with alternative treatments, including supplements and lifestyle modifications.
- To guide clinicians in customizing treatment regimens based on individual patient needs and risk tolerance.
Main Methods:
- Review of existing literature on HRT and alternative therapies for vasomotor symptoms.
- Analysis of efficacy, safety, and contraindications for each treatment modality.
- Consideration of patient-specific factors, including risk perception and medical history.
Main Results:
- Prescription HRT remains the most effective treatment for vasomotor symptoms.
- Lower doses, alternative forms, soy isoflavones, black cohosh, and neuroendocrine agents offer alternatives with varying efficacy and risk profiles.
- Bioidentical HRT shows no clear advantage over conventional HRT; lifestyle modifications are foundational and safe for all women.
Conclusions:
- A personalized approach is necessary, balancing symptom relief with acceptable risk.
- Clinicians must discuss therapeutic expectations and customize treatment plans.
- Alternative therapies and lifestyle changes provide viable options when HRT is contraindicated or undesired.
Related Concept Videos
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:28Menopause
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
01:30Adrenergic Agonists: Therapeutic Uses
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...